» Articles » PMID: 38761271

The Use of Indocyanine Green for Lateral Lymph Node Dissection in Rectal Cancer-preliminary Data from an Emerging Procedure: a Systematic Review of the Literature

Overview
Date 2024 May 18
PMID 38761271
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Lateral lymph node dissection (LLND) for rectal cancer is still not a widely established technique owing to the existing controversy between Eastern and Western countries and the lack of well-designed studies. The risk of complications and the paucity of long-term oncological results are significant drawbacks for further applying this technique. The use of indocyanine green (ICG) near-infrared (NIR) fluorescence for LLND appears as a promising technique for enhancing postoperative and oncological outcomes. This review aims to evaluate the emerging role of ICG during LLND and present the benefits of its application.

Materials And Methods: Systematic electronic research was conducted in PubMed and Google Scholar using a combination of medical subject headings (MeSH). Studies presenting the use of ICG during LLND, especially in terms of harvested lymph nodes, were included and reviewed. Studies comparing LLND with ICG (LLND + ICG) or without ICG (LLND-alone) were further analyzed for the number of lymph nodes and postoperative outcomes.

Results: In total, 13 studies were found eligible and analyzed for different parameters. LLND + ICG is associated with significantly increased number of harvested lateral lymph nodes (p < 0.05), minor blood loss, decreased operative time, and probably decreased urinary retention postoperatively compared with LLND-alone.

Conclusions: The use of ICG fluorescence during LLND is a safe and feasible technique for balancing postoperative outcomes and the number of harvested lymph nodes. Well-designed studies with long-term results are required to elucidate the oncological benefits and establish this promising technique.

Citing Articles

Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis.

Chen Z, Zhu D Front Oncol. 2025; 15:1500623.

PMID: 39959663 PMC: 11825347. DOI: 10.3389/fonc.2025.1500623.


ArtiSential versus conventional laparoscopic colorectal cancer surgery: a multicenter retrospective matched cohort study.

Pyo D, Lee Y, Min B, Lee J, Kim C, Oh H Int J Surg. 2025; 110(12):7630-7635.

PMID: 39806734 PMC: 11634190. DOI: 10.1097/JS9.0000000000002149.


Predictive value of methylene blue combined with indocyanine green in sentinel lymph node metastasis in breast cancer: a prospective pilot cohort study.

He Z, Guo F, Liu Y, Lin Y, Wang C, Zhou Y Front Oncol. 2024; 14:1433907.

PMID: 39445056 PMC: 11496266. DOI: 10.3389/fonc.2024.1433907.


Dissection of the Sympathetic Nerves Around the Mesorectum at the Abdominopelvic Border.

Badea T, Dogaru I, Filipoiu Z, Gheoca Mutu D, Filipoiu F Cureus. 2024; 16(9):e69091.

PMID: 39391403 PMC: 11466058. DOI: 10.7759/cureus.69091.

References
1.
Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700. PMC: 2714672. DOI: 10.1136/bmj.b2700. View

2.
Kim H, Choi G, Park J, Park S, Cho S, Seo A . S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection. Surg Endosc. 2019; 34(1):469-476. DOI: 10.1007/s00464-019-06830-x. View

3.
Tsukamoto S, Fujita S, Ota M, Mizusawa J, Shida D, Kanemitsu Y . Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg. 2020; 107(5):586-594. DOI: 10.1002/bjs.11513. View

4.
Bae J, Koh W, Kim H, Lee Y . Standardized Step-by-step Technique Using Surgical Landmarks in Robotic Lateral Pelvic Lymph Node Dissection. Ann Coloproctol. 2020; 37(1):58-60. PMC: 7989559. DOI: 10.3393/ac.2020.08.05. View

5.
Chang G, Halabi W, Ali F . Management of lateral pelvic lymph nodes in rectal cancer. J Surg Oncol. 2023; 127(8):1264-1270. DOI: 10.1002/jso.27317. View